These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 28401169)

  • 1. Epigenetic Regulations in Diabetic Nephropathy.
    Lu Z; Liu N; Wang F
    J Diabetes Res; 2017; 2017():7805058. PubMed ID: 28401169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.
    Yuan H; Reddy MA; Deshpande S; Jia Y; Park JT; Lanting LL; Jin W; Kato M; Xu ZG; Das S; Natarajan R
    Antioxid Redox Signal; 2016 Mar; 24(7):361-75. PubMed ID: 26492974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic nephropathy--emerging epigenetic mechanisms.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2014 Sep; 10(9):517-30. PubMed ID: 25003613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
    Sankrityayan H; Kulkarni YA; Gaikwad AB
    Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modifications in the pathogenesis of diabetic nephropathy.
    Reddy MA; Tak Park J; Natarajan R
    Semin Nephrol; 2013 Jul; 33(4):341-53. PubMed ID: 24011576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Mechanisms in Diabetic Kidney Disease.
    Thomas MC
    Curr Diab Rep; 2016 Mar; 16(3):31. PubMed ID: 26908156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in the pathogenesis of diabetic nephropathy.
    Li X; Lu L; Hou W; Huang T; Chen X; Qi J; Zhao Y; Zhu M
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):163-172. PubMed ID: 35130617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy.
    Lv J; Wu Y; Mai Y; Bu S
    J Diabetes Res; 2020; 2020():3960857. PubMed ID: 32656264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression analysis among microRNAs, long non-coding RNAs, and messenger RNAs to understand the pathogenesis and progression of diabetic kidney disease at the genetic level.
    Zhang L; Li R; He J; Yang Q; Wu Y; Huang J; Wu B
    Methods; 2017 Jul; 124():46-56. PubMed ID: 28577935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney.
    Cai M; Bompada P; Atac D; Laakso M; Groop L; De Marinis Y
    Biochem Biophys Res Commun; 2016 Jan; 469(1):108-113. PubMed ID: 26592666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of let-7a-3 is relevant to its down-expression in diabetic nephropathy by targeting UHRF1.
    Peng R; Liu H; Peng H; Zhou J; Zha H; Chen X; Zhang L; Sun Y; Yin P; Wen L; Wu T; Zhang Z
    Gene; 2015 Oct; 570(1):57-63. PubMed ID: 26049093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.
    Lu J; Huang Y; Zhang X; Xu Y; Nie S
    Pharmacol Res; 2021 Aug; 170():105520. PubMed ID: 33639232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone lysine methylation in diabetic nephropathy.
    Sun GD; Cui WP; Guo QY; Miao LN
    J Diabetes Res; 2014; 2014():654148. PubMed ID: 25215303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy.
    Gao J; Wang W; Wang F; Guo C
    Biomed Pharmacother; 2018 Oct; 106():543-552. PubMed ID: 29990842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
    Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting epigenetic regulators for treating diabetic nephropathy.
    Kushwaha K; Garg SS; Gupta J
    Biochimie; 2022 Nov; 202():146-158. PubMed ID: 35985560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of Identified Long Noncoding RNA in Diabetic Nephropathy.
    Li Y; Xu K; Xu K; Chen S; Cao Y; Zhan H
    J Diabetes Res; 2019; 2019():5383010. PubMed ID: 30891461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Gene Expression in Diabetic Nephropathy in Individuals With Type 1 Diabetes.
    Caramori ML; Kim Y; Goldfine AB; Moore JH; Rich SS; Mychaleckyj JC; Kirkpatrick D; Nickerson H; Krolewski AS; Mauer M
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E876-82. PubMed ID: 25871838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review.
    Wu H; Zhao M; Yoshimura A; Chang C; Lu Q
    Clin Rev Allergy Immunol; 2016 Jun; 50(3):333-44. PubMed ID: 26969025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.